Concepedia

Emma R. Parmee

ER

41

Publications

2.2K

Citations

26

H-Index

1989

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Emma R. Parmee is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

1989–2022

41

Publications

41

Human β3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides

Linda Brockunier, Emma R. Parmee, Hyun Ok et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 199 citations · Full text

, , +5

New catalysts for the asymmetric aldol reaction: chiral boranes prepared from .alpha.,.alpha.-disubstituted glycine arenesulfonamides

Emma R. Parmee, Orin Tempkin, Satoru Masamune et al. · Journal of the American Chemical Society · 1991 · 179 citations

, , +14

Discovery of MK-1454: A Potent Cyclic Dinucleotide Stimulator of Interferon Genes Agonist for the Treatment of Cancer

Wonsuk Chang, Michael D. Altman, Charles A. Lesburg et al. · Journal of Medicinal Chemistry · 2022 · 122 citations · Full text

, , +17

Crystal Structure of Human Phosphodiesterase 3B:  Atomic Basis for Substrate and Inhibitor Specificity

Giovanna Scapin, Sangita B. Patel, Jeffrey P. Varnerin et al. · Biochemistry · 2004 · 116 citations · Full text

, , +18

A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys.

M. H. FISHER, A Amend, Tom Bach et al. · Journal of Clinical Investigation · 1998 · 115 citations · Full text

, , +17

Rows per page

1–5 of 41